These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8759879)

  • 1. Multiple myeloma: almost all patients are cytogenetically abnormal.
    Zandecki M; Laï JL; Facon T
    Br J Haematol; 1996 Aug; 94(2):217-27. PubMed ID: 8759879
    [No Abstract]   [Full Text] [Related]  

  • 2. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of complex chromosomal aberrations in patients with multiple myeloma using multiplex fluorescence in situ hybridization].
    Jiang YQ; Chen LJ; Zhu Y; Qiu HR; Wang R; Xu JR; Lu H; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):441-4. PubMed ID: 20677154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of nonrandom chromosomal changes in multiple myeloma by comparative genomic hybridization.
    Avet-Loiseau H; Bataille R
    Blood; 1998 Oct; 92(8):2997-8. PubMed ID: 9763599
    [No Abstract]   [Full Text] [Related]  

  • 8. SnapShot: Multiple Myeloma.
    Braggio E; Kortüm KM; Stewart AK
    Cancer Cell; 2015 Nov; 28(5):678-678.e1. PubMed ID: 26555176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
    Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
    Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous cell type identification and premature chromosome condensation analysis in a case of multiple myeloma.
    Petkovic I; Agbor P; Hittelman WN
    Cancer Genet Cytogenet; 1989 Jun; 39(2):203-17. PubMed ID: 2502306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cell karyotype in multiple myeloma.
    Gould J; Alexanian R; Goodacre A; Pathak S; Hecht B; Barlogie B
    Blood; 1988 Feb; 71(2):453-6. PubMed ID: 3337907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytogenetics in myeloma.
    Zhan F; Sawyer J; Tricot G
    Leukemia; 2006 Sep; 20(9):1484-6. PubMed ID: 16926848
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma cell myeloma with lymphoplasmacytic morphology and cyclin D1 expression.
    Kajal B; Chang H
    Blood; 2016 Mar; 127(12):1619. PubMed ID: 27462671
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
    Lange K; Gadzicki D; Schlegelberger B; Göhring G
    Leuk Res; 2010 Aug; 34(8):1002-6. PubMed ID: 20022374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma cell myeloma. I. A new concept of disease biology].
    Barlogi B; Epstein J; Selvaniagam P; Alexanian R
    Gematol Transfuziol; 1991 Aug; 36(8):29-35. PubMed ID: 1752407
    [No Abstract]   [Full Text] [Related]  

  • 17. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic analysis of high-risk smoldering multiple myeloma.
    López-Corral L; Mateos MV; Corchete LA; Sarasquete ME; de la Rubia J; de Arriba F; Lahuerta JJ; García-Sanz R; San Miguel JF; Gutiérrez NC
    Haematologica; 2012 Sep; 97(9):1439-43. PubMed ID: 22331267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
    Fonseca R; Harrington D; Oken MM; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Blood EA; Rajkumar SV; Kay NE; Van Ness B; Greipp PR
    Cancer Res; 2002 Feb; 62(3):715-20. PubMed ID: 11830525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.